A , B , C , D , E , F , G , H , I , J , K , L , M , N , O , P , Q , R , S , T , U , V , W , X , Y , Z
Kürzel | Test | Einh. | Normalbereich | Hinweis | ||
M11 | M11 Rhizopus nigricans | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M12 | M12 Aureobasidiu pullulans | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M13 | M13 Phoma betae | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M16 | M16 Curvularia lunata | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M1 | M1 Penicillium not. | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M207 | M207 Aspergillus niger | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M2 | M2 Cladosporium herb. | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M2PK | M2 Pyruvatkinase | U/ml | 20.30 | - | 42.50 | MATERIAL: EDTA Methode: |
M2PKST | M2 Pyruvatkinase i.St. | U/mg | 0.00 | - | 8.00 | MATERIAL: Stuhl Methode: |
M3 | M3 Aspergillus fumigatus | RAST-KL | - | MATERIAL: Serum, METHODE: LIA; spez.IgE-RAST | ||
M4 | M4 Mucor rac. | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M5 | M5 Candida Albicans | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M6 | M6 Alternaria alt. | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M7 | M7 Botrytis cinerea | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M8 | M8 Helminthosp. halodes | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
M9 | M9 Fusarium species | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
MG | Magnesium | mmol/l | 0.600 | - | 1.000 | MATERIAL: Serum/Vollblut, METHODE: photometrisch |
MGH | Magnesium i.24h H. | mmol/24h | 3.00 | - | 5.00 | MATERIAL: 24h-Sammelharn, METHODE: photometrisch |
MGU | Magnesium i.Harn | mmol/l | - | MATERIAL: 24h-Sammelharn, METHODE: photometrisch | ||
MGV | Magnesium im Vollblut (EDTA) | mmol/Ery | 1.650 | - | 2.650 | MATERIAL: EDTA, METHODE: AAS |
CKMAKRO1 | Makro-CK Typ 1 | - | MATERIAL: Serum, | |||
CKMAKRO2 | Makro-CK Typ 2 | - | MATERIAL: Serum, | |||
MAKROS | Makroskopische Beschreibung | - | MATERIAL: Sputum | |||
MALAR | Malaria - Nachweis | - | MATERIAL: EDTA, METHODE: Mikroskopie | |||
MDA | Malondialdehyd | umol/l | 0.000 | - | 0.700 | MATERIAL: EDTA, METHODE: HPLC |
MSKREAU | Mandelsäure /g Krea i.H. | mg/g Krea | - | MATERIAL: Spontanharn,Methode: HPLC | ||
MSU | Mandelsäure i.H. | mg/l | - | MATERIAL: Spontanharn, METHODE: HPLC | ||
MNU | Mangan i.H. | ug/l | 1.250 | - | 2.250 | MATERIAL: Spontanharn; Methode: photom. |
MN | Mangan im Serum | ug/l | 0.30 | - | 1.30 | MATERIAL: Serum/Vollblut, METHODE:AAS |
MNV | Mangan im Vollblut (EDTA) | ug/l | 6.000 | - | 11.000 | MATERIAL: EDTA, METHODE: AAS |
MBL | Mannose-bindendes-Lektin | ng/ml | > | 540.0 | MATERIAL: Serum, METHODE: | |
MAPROTILIN | Maprotilin | ng/ml | 75.00 | - | 130.00 | MATERIAL: Serum/Vollblut METHODE: LC-MS |
MSG | Masern IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELFA | |||
MSGQUANT | Masern IgG Impftiter | - | MATERIAL: Serum/Vollblut, METHODE: ELFA | |||
MSM | Masern IgM | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
MMRIMPF | Masern Mumps Röteln Immunstaten | - | MATERIAL: Serum/Vollblut | |||
MSPCRU | Masernvirus (RNA) PCR i.H. | - | MATERIAL: Spontanharn, METHODE: PCR | |||
MSPCR | Masernvirus RNA (PCR) | - | MATERIAL: Serum, Na/RA-Abstrich METHODE: PCR | |||
MCA | MCA | U/ml | 0.00 | - | 11.00 | MATERIAL: Serum/Vollblut, METHODE: EIA |
MCH | MCH | pg | 27.00 | - | 32.00 | MATERIAL: EDTA-Blut |
MCHC | MCHC | % | 29.5 | - | 36.0 | MATERIAL: EDTA-Blut |
MCV | MCV | fl | 77.00 | - | 96.00 | MATERIAL: EDTA-Blut |
MGKZ | Megakaryozyten | % | - | MATERIAL: EDTA, | ||
MIA | Melanoma Inhib. Activator | pg/ml | < | 1622.0 | MATERIAL: Serum, METHODE: ELISA | |
MELAT | Melatonin | pg/ml | 3.80 | - | 80.40 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
MELATH | Melatoninsulfat i.H. | ug/24h | 7.50 | - | 58.10 | MATERIAL: 24h-Sammelharn, Methode: EIA |
Melperon | Melperon | ng/ml | 30.0 | - | 100.0 | MATERIAL: Serum/Vollblut, METHODE: HPLC |
MENG | Meningokokken AK IgG | Titer | 100.0 | - | 1000.0 | MATERIAL: Serum/Vollblut, METHODE: IIF |
MENM | Meningokokken AK IgM | Titer | 50.0 | - | 1000.0 | MATERIAL: Serum/Vollblut, METHODE: IIF |
MESCH | Mescalin i.H. | ug/l | < | 6.00 | MATERIAL: Serum, METHODE: LC-MS | |
METAMIZOL | Metamizol | - | MATERIAL: Serum, Methode: LC-MS | |||
METAMPH | Metamphetamine (U) | ng/ml | 0.0 | - | 1000.0 | MATERIAL: Spontanharn, METHODE: EMIT |
META | Metamyelozyten | % | 0.00 | - | 1.00 | MATERIAL: EDTA, |
MNNS | Metanephrin (P) | ng/l | < | 100.0 | MATERIAL: 5ml EDTA-Plasma; METHODE: LC-MS/MS | |
MNNH | Metanephrin i.24h H. | ug/24h | 0.00 | - | 374.70 | MATERIAL: 24h-Sammelharn angesäuert, METHODE: HPLC |
METS | Methadon (S) | ng/ml | - | MATERIAL: Serum/Vollblut; METHODE: FPIA | ||
METH | Methadon (U) | ng/ml | 0.0 | - | 300.0 | MATERIAL: Spontanharn, METHODE: EMIT |
EDDPH | Methadon-Metabolit (EDDP) i.H. | ng/ml | 0.0 | - | 100.0 | MATERIAL: Spontanharn, METHODE: CEDIA |
METHPROG | Methadonprogramm | - | ||||
METHB | Methämoglobin | % | 0.00 | - | 1.00 | MATERIAL: EDTA, METHODE: Spektralphotometrie |
MQUALONH | Methaqualonsäure i.H. | ug/l | < | 6.00 | MATERIAL: Spontanharn, METHODE: LC-MS | |
MRSA | Methicillin res.Staph.aureus | - | MATERIAL: Abstrich; Methode: Kultur | |||
MTX | Methotrexat | umol/l | - | MATERIAL: Serum/Vollblut od. Heparin; METHODE: CMIA | ||
METHECGOS | Methylecgonin (S) | ug/l | < | 2.0 | MATERIAL: Serum, METHODE: FPIA | |
MHSU | Methylhippursäure i.H. | g/l | 0.0000 | - | 1.5000 | MATERIAL: Spontanharn, METHODE: HPLC |
METHISTHKR | Methylhistamin /g Krea i.H. | ug/g Krea | 34.0 | - | 177.0 | MATERIAL: Spontanharn METHODE: LC-MS |
MMSU | Methylmalonsäure /g Krea i.H. | mg/g Kreat | < | 3.760 | MATERIAL: Harn, METHODE: LC-MS/MS | |
MMS | Methylmalonsäure im Serum | ug/l | 0.00 | - | 32.00 | MATERIAL: Serum/Plasma METHODE: LCMS |
MPHS | Methylphenidat (Ritalin) | ng/ml | 12.00 | - | 79.00 | MATERIAL: Serum, METHODE: LC-MS |
MPHH | Methylphenidat i.H. | ug/l | < | 6.00 | MATERIAL: Spontanharn, METHODE: LC-MS | |
MHSOCR_AM | MHS/oCresol Paket | - | MATERIAL: Spontanharn, METHODE: HPLC | |||
MIANSERIN | Mianserin | ng/ml | 15.00 | - | 70.00 | MATERIAL: Serum/Vollblut METHODE: LC-MS |
STMIK_MAX | Mikrobiomanalyse Maxi i.St. | - | MATERIAL: Stuhl | |||
STMIK_MIN | Mikrobiomanalyse Mini i.St. | - | MATERIAL: Stuhl | |||
STFLORA | Mikroökologische Stuhlflora | - | MATERIAL: Stuhl, METHODE: Klassische Stuhlanalyse über Anzucht | |||
MILNACIP | Milnacipran | ng/ml | 100.00 | - | 150.00 | MATERIAL: Serum/Vollblut METHODE: HPLC |
MINERALSTV | Mineralstoffanalyse Vollblut | - | MATERIAL: EDTA + Heparin, METHODE: GC-MS, AAS | |||
MIRTA | Mirtazapin | ng/ml | 30.00 | - | 80.00 | MATERIAL: Serum; Methode: HPLC |
MPV | Mittl.Thrombozyten Vol. (MPV) | fl | 5.90 | - | 12.00 | MATERIAL: EDTA, |
MRH | Mittleres Retikulozyten Hb. | pg | 28.00 | - | 35.00 | MATERIAL: EDTA, |
MKP1 | MKP1-Untersuchung | - | MATERIAL: EDTA-Blut+Vollblut | |||
MKP2 | MKP2-Untersuchung | - | MATERIAL: EDTA-Blut+Vollblut | |||
MOCLOBEMID | Moclobemid | µg/l | 300.0 | - | 1000.0 | MATERIAL: Serum, Methode: LC-MS |
MO | Molybdän im Serum | ug/l | < | 1.000 | MATERIAL: Serum/Vollblut; METHODE: ICP-MS | |
MOV | Molybdän im Vollblut (EDTA) | ug/l | 0.20 | - | 1.30 | MATERIAL: EDTA, METHODE: ICP-MS |
MONOP | Monozyten | % | - | MATERIAL: Punktat | ||
MONO | Monozyten | % | 2.00 | - | 10.00 | MATERIAL: EDTA, |
MONOA | Monozyten (abs.) | /µl | 0.0 | - | 800.0 | |
MB | Morphologie im Diff.BB | - | MATERIAL: EDTA, METHODE: Mikroskopie | |||
MBP | Morphologie im Punktat | - | MATERIAL: Punktat, METHODE: Mikroskopie | |||
MOXIFLOX | Moxifloxacin | mg/l | - | MATERIAL: Serum; METHODE: LC-MS | ||
MPL_MUT | MPL W515L/K Mutationsnachweis | - | MATERIAL: EDTA 5ml; Methode: PCR | |||
MUCON | Muconsäure i.H. | mg/l | 0.00 | - | 1.60 | MATERIAL: Spontanharn, METHODE: HPLC |
MUMPSG | Mumps IgG | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
MUMPSQUANT | Mumps IgG Impftiter | U/ml | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | ||
MUMPSM | Mumps IgM | - | MATERIAL: Serum/Vollblut, METHODE: ELISA | |||
MUSKAK | Musk.sp.Rezept.Tyrosin-Kinase | U/ml | < | 0.40 | MATERIAL: Serum; Methode: ELISA | |
MCVAK | Mut.citrull. Vimentin-AK | U/ml | 0.00 | - | 20.00 | MATERIAL: Serum; Methode: EIA |
MX1 | MX1 Schimmelpilze | RAST-KL | - | MATERIAL: Serum, METHODE: LIA | ||
MYTUBPCR | Mycobact.tuberculosis DNA (PCR) | - | MATERIAL: Sputum, METHODE: PCR | |||
MPA | Mycophenolsäure (MPA) | mg/l | 1.00 | - | 4.00 | MATERIAL: EDTA+Serum Methode: HPLC |
MYGENPCRU | Mycopl. genitalium (PCR) i.H. | - | MATERIAL: Spontanharn, METHODE: PCR | |||
MYGENPCR | Mycopl. genitalium DNA (PCR) | - | MATERIAL: Abstrich; METHODE: PCR | |||
MYPNEUPCR | Mycopl.pneumoniae DNA (PCR) | - | MATERIAL: Abstrich/Harn; METHODE: PCR | |||
MYPNEUG | Mycoplasma pneum. IgG | U/ml | 0.00 | - | 25.00 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
MYPNEUM | Mycoplasma pneum. IgM | U/ml | 0.00 | - | 25.00 | MATERIAL: Serum/Vollblut, METHODE: ELISA |
MYKULT | Mycoplasmen Kultur | 0.0 | - | 20.0 | MATERIAL: Serum/Vollblut, METHODE: | |
MAGM | Myelin assoz.Glycoprot. IgM-AK | Titer | 0.0 | - | 10.0 | MATERIAL: Serum, METHODE: IFT |
MOGG | Myelin-Oligodend.-Glykoprotein | Titer | - | MATERIAL: Serum, METHODE: IFT | ||
MYO | Myoglobin | ug/l | 19.0 | - | 72.0 | MATERIAL: Serum/Vollblut, METHODE: ECLIA |
MYOH | Myoglobin i.H. | ug/l | 0.00 | - | 0.10 | MATERIAL: Spontanharn, METHODE: turbidimetrisch |
MYOSITISAK | Myositis Ak Screening | - | MATERIAL: Serum/Vollblut, METHODE: IBLOT | |||
MYOGBLOT | Myositis IgG Lineblot | - | MATERIAL: Serum/Vollblut, METHODE: IBLOT |